Ajanta Pharma Limited (BOM:532331)
3,640.35
-25.30 (-0.69%)
At close: Aug 21, 2026
Ajanta Pharma Revenue
Ajanta Pharma had revenue of 16.26B INR in the quarter ending June 30, 2026, with 24.82% growth. This brings the company's revenue in the last twelve months to 57.76B, up 20.19% year-over-year. In the fiscal year ending March 31, 2026, Ajanta Pharma had annual revenue of 54.53B with 17.31% growth.
Revenue (ttm)
57.76B
Revenue Growth
+20.19%
P/S Ratio
7.87
Revenue / Employee
6.00M
Employees
9,628
Market Cap
454.74B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 54.53B | 8.05B | 17.31% |
| Mar 31, 2025 | 46.48B | 4.39B | 10.44% |
| Mar 31, 2024 | 42.09B | 4.66B | 12.45% |
| Mar 31, 2023 | 37.43B | 4.02B | 12.02% |
| Mar 31, 2022 | 33.41B | 4.51B | 15.62% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 331.19B |
| Lupin | 299.67B |
| Jubilant Pharmova | 86.08B |
| Abbott India | 70.04B |
| Granules India | 56.32B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 39.55B |
| AstraZeneca Pharma India | 24.32B |
Ajanta Pharma News
- 23 days ago - Ajanta Pharma Transcript: Q1 26/27 - Transcripts
- 23 days ago - Ajanta Pharma Slides: Q1 2027 - Filings
- 23 days ago - Ajanta Pharma Quarterly report: Q1 2027 - Filings
- 6 weeks ago - Pharma sector stocks today, July 6: Panacea Biotec surges 2.47%, Ajanta Pharma gains 1.48%, Glenmark Pharma up 1.29% - Business Upturn
- 7 weeks ago - Ajanta Pharma receives USFDA EIR for Paithan facility after inspection - Business Upturn
- 7 weeks ago - Ajanta Pharma receives US FDA's EIR for Paithan facility inspection - Business Upturn
- 7 weeks ago - Pharma sector stocks today, June 30: Ajanta Pharma falls 2.96%, Dr. Reddy's Lab down 1.77%, Aurobindo Pharma up 1.41% - Business Upturn
- 2 months ago - Top losers in morning trade: gujarat state petronet at ₹268.35 down 7.13%, valor estate at ₹114.34 down 2.87%, ajanta pharma at ₹3,045.00 down 2.75% - Business Upturn